WebThe alfapump® system is not currently approved in the United States or Canada.In the United States and Canada, the alfapump® system is currently under clinical investigation (POSEIDON Study) and is being … WebJul 13, 2011 · Sequana Medical announced today that it has received CE Mark approval for the commercial sale of its ALFApump™ System. Over the coming months, the company …
Sequana Medical… Newton Biocapital - Life Sciences Investments
WebMar 8, 2024 · Alfapump® patients with new catheters required less reinterventions (26% versus 57% with old catheters, p = 0.049). Transplant-free survival at 1 year was 25% in alfapump® and 65% in ... WebMay 19, 2015 · Device: alfapump Drug: salt-poor Human Albumin solution. Not Applicable. Detailed Description: The study will be a single centre, open-label trial. The patients will have a diagnosis of refractory ascites and will meet specified inclusion/exclusion criteria Informed consent will be obtained from all patients. All patients will have an alfapump ... large hospitals in alabama
Alfapump® System in the Treatment of Refractory or …
WebOct 4, 2024 · The alfapump® system is not currently approved in the United States or Canada. In the United States and Canada, the alfapump® system is currently under clinical investigation (POSEIDON Study) and is being studied in adult patients with refractory or … WebThe alfapump® system is not currently approved in the United States or Canada. In the United States and Canada, the alfapump® system is currently under clinical … WebOct 15, 2024 · FDA Approves First Artificial Iris. The U.S. Food and Drug Administration (FDA) has approved the world’s first artificial iris, a breakthrough development for those suffering with severe vision loss. The iris is the colored part of the eye that surrounds the central pupil. The iris plays an important role in the function of the eye. large hot handbags free shipping